Effects of aloe, aloesin, or propolis on the pharmacokinetics of benzo [a]pyrene and 3-OH-benzo[a]pyrene in rats

Journal of Toxicology and Environmental Health - Part A

Volumn 68, Issue 23-24, 2005, Pages 2227-2238

  Cao, Dianxiu ^a   Chi, Ho Yoon ^a   Beom, Soo Shin ^a   Chul, Hwan Kim ^a   Eun, Seok Park ^a   Sun, Dong Yoo ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBENZO[A]PYRENE; BENZO[A]PYRENE; EMODIN; PROPOLIS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILIARY EXCRETION; BLOOD CHEMISTRY; CONTROLLED STUDY; DRUG MEGADOSE; FECES; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

ALOE; ANIMALS; BENZO(A)PYRENE; BENZOPYRENES; BILE; BODY WEIGHT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMONES; FECES; GLUCOSIDES; MALE; PLANT EXTRACTS; PROPOLIS; RATS; RATS, SPRAGUE-DAWLEY; URINE;

ALOE; ANIMALIA;

EID: 28744453048     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390500182164     Document Type: Article

References (21)

1. Bevan, D. R., and Weyand, E. H. 1988. Compartmental analysis of the disposition of benzo[a]pyrene in rats. Carcinogenesis 9:2027-2032.
2. Bouchard, M., and Viau, C. 1997. Urinary excretion of benzo[a]pyrene metabolites following intravenous, oral, and cutaneous benzo[a]pyrene administration. Can. J. Physiol. Pharmacol. 75:185-192.
3. Burdock, G. A. 1998. Review of the biological properties and toxicity of bee propolis (propolis). Food Chem. Toxicol. 36:347-363.
4. Conney, A. H., Chang, R. L., Jerina, D. M., and Wei, S. J. 1994. Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite. Drug Metab. Rev. 26:125-163.
5. Gozukara, E. M., Guengerich, F. P., Miller, H., and Gelboin, H. V. 1982. Different patterns of benzo[a]pyrene metabolism of purified cytochromes P-450 from methylcholanthrene, beta-naphthoflavone and phenobarbital treated rats. Carcinogenesis 3:129-133.
6. Hattemer-Frey, H. A., and Travis, C. C. 1991. Benzo-a-pyrene: Environmental partitioning and human exposure. Toxicol. Ind. Health. 7:141-157.
7. Jongeneelen, F. J., Leijdekkers, C. M., and Henderson, P. T. 1984. Urinary excretion of 3-hydroxy-benzo[a]pyrene after percutaneous penetration and oral absorption of benzo[a]pyrene in rats. Cancer Lett 25:195-201.
8. Keith, L. H. 1997. Environmental endocrine disruptors: A handbook of property data,, pp. 206-223. New York: John Wiley & Sons.
9. Kim, H. S., and Lee, B. M. 1997. Inhibition of benzo[a]pyrene-DNA adduct formation by Aloe barbadensis Miller. Carcinogenesis 18:771-776.
10. Mitchell, C. E. 1983. The metabolic fate of benzo[a]pyrene in rats after inhalation. Toxicology 28:65-73.
11. Moir, D., Viau, A., Chu, I., Withey, J., and McMullen, E. 1998. Pharmacokinetics of benzo[a]pyrene in the rat. J. Toxicol Environ. Health A. 53:507-530.
12. Mullaart, E., Buytenhek, M., Brouwer, A., Lohman, P. H., and Vijg, J. 1989. Genotoxic effects of intragastrically administered benzo[a]pyrene in rat liver and intestinal cells. Carcinogenesis 10:393-395.
13. Pietta, P. G., Gardana, C., and Pietta, A. M. 2002. Analytical methods for quality control of propolis. Fitoterapia 73:S7-S20.
14. Ramesh, A., Inyang, F., Hood, D. B., Archibong, A. E., Knuckles, M. E., and Nyanda, A.M. 2001a. Metabolism, bioavailability, and toxicokinetics of benzo(alpha)pyrene in F-344 rats following oral administration. Exp. Toxicol. Pathol. 53:275-290.
15. Ramesh, A., Greenwood, M., Inyang, F., and Hood, D. B. 2001b. Toxicokinetics of inhaled benzo[a]pyrene: plasma and lung bioavailability. Inhal. Toxicol. 13:533-555.
16. Tang, Y., Donnelly, K. C., Tiffany-Castiglioni, E., and Mumtaz, M. M. 2003. Neurotoxicity of polycyclic aromatic hydrocarbons and simple chemical mixtures. J. Toxicol. Environ. Health A 66:919-940.
17. van de Wiel, J. A., Fijneman, P. H., Duijf, C. M., Anzion, R. B., Theuws, J. L., and Bos, R. P. 1993. Excretion of benzo[a]pyrene and metabolites in urine and feces of rats: Influence of route of administration, sex and long-term ethanol treatment. Toxicology 80:103-115.
18. Weyand, E. H., and Bevan, D. R. 1987. Species differences in disposition of benzo[a]pyrene. Drug Metab. Dispos. 15:442-448.
19. Withey, J. R., Law, F. C., and Endrenyi, L. 1991. Pharmacokinetics and bioavailability of pyrene in the rat. J. Toxicol. Environ. Health 32:429-447.
20. Yamazaki, H., and Kakiuchi, Y. 1989. The uptake and distribution of benzo(a)pyrene in rat after continuous oral administration. Toxicol. Environ. Chem. 24:95-104.
21. Yagi, A., and Takeo, S. 2003. Anti-inflammatory constituents, aloesin and aloemannan in aloe species and effects of tanshinon VI in Salvia miltiorrhiza on heart. Yakugaku Zasshi 123:517-532.